The benefit of the PARP inhibitor in patients with germline BRCA pathogenic variants remains evident 10 years after the first ...
We recently published a list of 10 Best Safe Stocks To Buy According to Analysts. In this article, we are going to take a ...
Amgen appointed Naveen Gullapalli, former Novartis executive, as Managing Director of Amgen India. Gullapalli will lead Amgen ...
Naveen Gullapalli has been appointed as Managing Director of Amgen's India Technology and Innovation Hub in Hyderabad, ...
Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental ...
Hosted on MSN12h
Amgen (AMGN) Stock Sinks As Market Gains: Here's WhyThe most recent trading session ended with Amgen (AMGN) standing at $273.41, reflecting a -0.85% shift from the previouse trading day's closing. The stock fell short of the S&P 500, which registered a ...
Following recently signed global license agreement with Synaffix, EO-1022 leverages the company's GlycoConnect® and HydraSpace® ADC technologies for glycan site-specific conjugation and SYNstatin Etm ...
Pharmaceutical and biotech businesses were enthusiastic about the UPC before the court opened, but so far there has only been ...
Bangalore: Biocon has sold Eighty Lacs equity shares of Syngene International Limited for Rs. 686 crores. The transacted ...
The Holywood golfer registered nine top tens on last season’s Race to Dubai, including a runner-up finish in Italy, while he ...
1h
Licensing agreement gives Elevation Oncology access to Synaffix's ADC technology for one program in combination with SYNstatin EElevation Oncology nominates a novel HER3 ADC candidate EO-1022 ...
CPI data matched expectations; Goods inflation rose to its highest level since May 2023. Albertson’s terminates merger with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback